OptiDrop Platform

CalendarToday
timer
1 min read
OptiDrop Platform Blog Image

Overview:

Recently, the Centre for Cellular and Molecular Platforms (C-CAMP) in Bengaluru has developed a new platform called OptiDrop.

About OptiDrop Platform

  • It is an innovative microfluidic chip-based platform that simplifies and reduces the cost of studying single cells.
  • It employs a novel approach that enables precise and cost-effective analysis of single cells encapsulated in droplets.
  • The platform’s unique features include live data visualisation, a smaller data footprint, and a ‘closed’ system design that prevents external contamination.
  • This research was supported by the Biotechnology Industry Research Council (BIRAC), the Department of Science and Technology (DST), and the Ministry of Human Resource Development (MHRD).

Applications:

  • This cutting-edge technology has potential applications in diagnostics, therapeutics, agriculture, and animal health.
  • It helps in studying the impact on individual cells during a drug screen, environment control (water contamination counter), detection and sorting of CAR-T cells in immuno-oncotherapeutics, selection of CRISPR-modifiedsingle cells and selection of high-efficiency clones in single-cell genomics

What is C-CAMP?

  • It is an initiative supported by the Department of Biotechnology, Govt of India is a catalyst of cutting-edge research and innovation in the life sciences since 2009.

It is mandated to promote entrepreneurship and innovation. It has created and fostered an entrepreneur-friendly culture in and around the Academic/Research environment through its involvement in Seed Funding Schemes for Startups.


Q1: What is a Microfluidic chip?

It is referred to as lab-on-a-chip devices, which are miniature platforms that manipulate and analyze small volumes of fluids. These chips integrate various functions, such as mixing, pumping, and sensing, onto a compact substrate, enabling precise control over minute amounts of liquids.

Source: Bengaluru’s C-CAMP develops platform for studying single cells cost-effectively